Wound antibacterial dressing
By doping manganese oxide-doped phycocyanin in bacterial cellulose, combining bacterial cellulose to prepare wound antibacterial dressings, and using 600nm laser irradiation to generate ROS, the problems of insufficient antibacteriality of traditional dressings and poor stability of manganese oxide nanoparticles are solved, and the problem of insufficient antibacteriality of manganese oxide nanoparticles is achieved. It has significant antibacterial and healing effects.
Patent Information
- Application Number
- CN202411025229.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
Traditional medical dressings cannot effectively inhibit wound infection and cannot promote wound healing. The antibacterial activity of bacterial cellulose is insufficient, the manganese oxide nanoparticles have poor stability and poor dispersion, making it difficult to meet the needs of wound antibacterial and healing.
Doping manganese oxide-doped phycocyanin into bacterial cellulose, the manganese oxide nanoparticles are generated by reacting phycocyanin with manganese dichloride, and wound antibacterial dressing is prepared in combination with bacterial cellulose, and ROS is generated by 600nm laser irradiation to significantly Improve antibacterial properties.
The prepared wound antibacterial dressings show significant antibacterial and promote cell proliferation effects, have good biocompatibility and cell affinity, and can kill bacteria efficiently under laser irradiation, avoid drug resistance, and enhance the anti-dressing Oxidation properties promote wound healing.
Smart Images

Figure BDA0004968348520000061 
Figure BDA0004968348520000062
Abstract
Description
Technical Field
[0001] The invention relates to a medical preparation, in particular to a dressing containing phycocyanin. The dressing has an antibacterial effect and is suitable for inhibiting bacterial infection of wounds. Technical Background
[0002] The increasing number of skin problems and the growing demand for dressings that can protect skin tissue and reduce infection have driven the rapid growth of the market size of my country's medical dressing industry. Traditional medical dressings still have the following three main problems to be solved: ① It is impossible to observe the healing of the wound, and frequent dressing changes will also cause secondary injuries to the wound, causing pain to the patient; ② It is unable to resist infection; ③ It cannot provide a good healing environment for wound healing and cannot promote wound healing. Bacterial cellulose is a natural polysaccharide polymer synthesized by bacteria. It has a linear polymer structure and is composed of many glucose molecules connected by β-1,4-glycosidic bonds. This structure gives bacterial cellulose excellent mechanical strength, heat resistance, solvent resistance, biocompatibility and biodegradability. It can be used as a biodegradable wound dressing to promote wound healing and reduce the occurrence of infection and inflammation. However, the antibacterial activity of bacterial cellulose is low and cannot meet the antibacterial needs of clinical wound healing.
[0003] Phycocyanin (C-Phycocyanin, C-PC) is a light-harvesting protein derived from spirulina and cyanobacteria cells. In GB2760-2014 "National Food Safety Standard for the Use of Food Additives", phycocyanin is listed as a natural food colorant allowed for use in my country and can be used in the production of beverages, cakes, candies and other foods. In addition to being widely used in the food industry as a food colorant, phycocyanin has good water solubility and physiological activities such as antioxidant, anti-cancer, anti-inflammatory, and immune enhancement. Phycocyanin has good cell affinity and can promote cell proliferation; and phycocyanin can be used as a photosensitizer to efficiently produce reactive oxygen under laser irradiation, showing good anti-tumor and antibacterial effects. For example, Yang Yingying used the MTT method to study the in vitro growth inhibition of phycocyanin and its enzymatic hydrolysate on cervical cancer cells Hela and melanoma cells B16, and found that phycocyanin has a good anti-tumor effect (Yang Yingying. Study on the separation, purification, enzymatic hydrolysis and anti-tumor activity of phycocyanin [D]. Tianjin Commercial University, 2009.). Runze Liu reviewed the antioxidant and anti-inflammatory activities of phycocyanin (Phycocyanin: Anti-inflammatory effect and mechanism, Biomedicine & Pharmacotherapy, 2022, 153, 113362). However, there are no reports on phycocyanin as an antibacterial wound dressing.
[0004] In recent years, manganese oxide nanoparticles have attracted widespread attention in the field of antibacterial due to their good stability, low production cost and ability to simulate the cleanliness of natural enzymes. Manganese oxide nanoparticles have good oxidase-like and peroxidase-like activities, can achieve effective antibacterial cleanliness by generating reactive oxygen species, and can avoid drug resistance. Manganese oxide nanoparticles are an important oxide nanomaterial with good antioxidant, anti-inflammatory and biocompatibility properties. In addition, manganese oxide also has antibacterial, wound healing and tissue regeneration effects, so its application in the medical field is receiving widespread attention. However, manganese oxide nanoparticles still have the characteristics of poor stability and poor dispersibility, and are still limited in their antibacterial effects. Summary of the invention
[0005] The technical problem to be solved by the present invention is to provide an antibacterial wound dressing, which has significant effects of antibacterial and promoting cell proliferation.
[0006] The technical solution of the present invention to solve the above problems is:
[0007] An antibacterial wound dressing, which is made of bacterial cellulose and 15% of the weight of the bacterial cellulose manganese oxide doped with phycocyanin; wherein the manganese oxide doped with phycocyanin is made by the following method:
[0008] Phycocyanin is added into pure water to prepare a phycocyanin aqueous solution; manganese dichloride in an amount of 0.6 times the weight of the phycocyanin is added into pure water to prepare a manganese dichloride solution; the manganese dichloride solution and the phycocyanin aqueous solution are mixed evenly, a sodium hydroxide aqueous solution is added dropwise, the pH value is adjusted to 9, and the reaction is carried out at room temperature for 8 hours; and the manganese oxide-doped phycocyanin is obtained by dialyzing and freeze-drying.
[0009] It can be seen from the above-mentioned method for preparing manganese oxide-doped phycocyanin that there are a large number of manganese ions in the manganese dichloride solution, which chelate with the side chains on the amino acids of phycocyanin. After the solution is adjusted to alkaline, the manganese ions and hydroxide ions react to form manganese oxide nanoparticles to prepare manganese oxide-doped phycocyanin.
[0010] The antibacterial wound dressing described in the present application is prepared by the following method: adding the bacterial cellulose and manganese oxide-doped phycocyanin into water, dripping sodium hydroxide aqueous solution, adjusting the pH value to 11, pouring into a mold to form, and freeze-drying to obtain the antibacterial wound dressing.
[0011] The antibacterial wound dressing of the present invention has good biocompatibility and cell affinity. The antibacterial wound dressing of the present invention contains manganese oxide doped with phycocyanin, which can produce ROS and kill bacteria under 600nm laser irradiation, thereby showing good antibacterial properties. The antibacterial wound dressing of the present invention has good antibacterial properties and does not produce drug resistance. While ensuring good antibacterial properties, the antibacterial wound dressing of the present invention synergistically enhances the antioxidant properties of the dressing, has a good protective effect on cells, promotes cell proliferation, and achieves good anti-infection and healing promotion effects. DETAILED DESCRIPTION
[0012] The preparation method and effects of the present invention are further described in detail with specific examples below.
[0013] Example 1
[0014] 1. Preparation of manganese oxide doped phycocyanin
[0015] 100 mg of phycocyanin was dissolved in 20 ml of pure water to prepare a phycocyanin aqueous solution; 60 mg of manganese dichloride was dissolved in 3 ml of pure water to prepare a manganese dichloride solution; the manganese dichloride solution was slowly added dropwise to the phycocyanin aqueous solution and mixed evenly; sodium hydroxide aqueous solution (0.1 mol / L) was slowly added dropwise to adjust the pH to 9 and stirred for 8 h; after dialysis for 24 hours, the solution was freeze-dried to obtain manganese oxide-doped phycocyanin. Phycocyanin was purchased from Macklin, item number C875820-25g.
[0016] The red light spectrum of the above-mentioned manganese oxide-doped phycocyanin was detected by Thermo Scientific iS20 Fourier transform infrared spectrometer, and the results are as follows: IR: v (cm -1 ), 3239, 1671, 1622. From the infrared data, it can be found that manganese oxide doped phycocyanin contains amide and ester bonds, indicating that the structure of phycocyanin itself is not destroyed. The prepared manganese oxide doped phycocyanin is added into pure water, and it can be seen that the manganese oxide doped phycocyanin solution has good dispersibility and stability. The particle size can be measured by dynamic light scattering particle size analyzer (DLS) to be 180nm.
[0017] 2. Preparation of antibacterial wound dressings
[0018] Weigh 100 mg of bacterial cellulose (purchased from Tianlu Nano Company, model NFC-31L1) and 15 mg of manganese oxide-doped phycocyanin aqueous solution (1 mg / mL), add them into water, stir to mix, slowly add sodium hydroxide aqueous solution (0.1 mol / L), adjust the pH to 11, pour into a mold to form, and freeze-dry to obtain an antibacterial wound dressing.
[0019] 3. Performance testing of antibacterial wound dressings
[0020] 3.1. Swelling degree test
[0021] At room temperature, take the wound antibacterial dressing, place it in a 37℃ oven for dehydration and air drying for 48 hours, and weigh it accurately to obtain the weight W o Soak it in water at room temperature until it reaches swelling equilibrium, wipe off excess water on the surface of the antibacterial wound dressing with filter paper, and measure the weight of the antibacterial wound dressing again to obtain the weight W e Then the swelling rate of the wound antibacterial dressing is calculated according to the following formula: Swelling rate (%) = ((We-W0) / W0)*100%. The swelling rate of the wound antibacterial dressing prepared in this example is 813%.
[0022] 3.2 Tensile strength test
[0023] The prepared swelling-balanced antibacterial wound dressing was tested for its tensile strength using a Zwick / Roell 2202 universal material testing machine (Zwick, Germany).
[0024] According to the above method, the tensile strength of the prepared antibacterial wound dressing was 142 MPa.
[0025] 3.3 Cell experiments
[0026] Cell seeding
[0027] The prepared antibacterial wound dressing was transferred to a 24-well plate, and DMEM cell culture medium was added and placed in an incubator for pre-wetting. Mouse epithelial cells L929 were inoculated on the antibacterial wound dressing (2.0×10 6 Cells / 100 μL / hydrogel) were cultured in a 37°C, 5% CO2 incubator for 4 hours to allow the cells to better adhere to the wall. Then 1 mL of culture medium was added to each culture well and cultured in a 37°C, 5% CO2 incubator. The culture medium was replaced every 2 days.
[0028] 3.3.2. Cell viability evaluation
[0029] Take out the 24-well culture plate at 1d, 3d, and 7d, add 80uL MTT solution to each well, and continue to culture in the incubator for 4h. Aspirate the culture medium, add 750uL hydrochloric acid isopropanol solution (0.4mol / L) to each well, incubate in the incubator for 15min, mix well by blowing, take 200uL from each well and transfer it to the 96-well culture plate, and use an automatic microplate reader to detect the light absorption value (OD value) of each well at 540nm.
[0030] Cell viability % = ((test cell OD - blank OD) / (control cell OD - blank OD)) × 100
[0031] The cell viability of the prepared antibacterial wound dressing was tested according to the above method and is shown in Table 1.
[0032] Table 1 Cell viability of antimicrobial wound dressings
[0033] Time (day) 1 3 7 Cell viability % 107 133 151
[0034] It can be seen from Table 1 that the prepared antibacterial wound dressing has low cytotoxicity, high cell affinity and little effect on cell activity.
[0035] Cell adhesion
[0036] The penetration and adhesion of cells were observed macroscopically (MTT staining). Mouse epithelial cells L929 were implanted on wound antibacterial dressings and cultured in vitro for 3 days. The culture medium was aspirated and washed with PBS 3 times, 10 minutes each time. 80uL of MTT solution was added to each well and placed in an incubator for further culture for 4 hours. The culture medium was aspirated and 750μL of hydrochloric acid isopropanol solution (0.4mol / L) was added to each well. The wells were incubated in an incubator for 15 minutes. After mixing by blowing, 200μL of each well was transferred to a 96-well culture plate. The light absorption value (OD value) of each well was detected at 540nm using an automatic microplate reader.
[0037] Cell adhesion rate % = ((test cell OD-blank OD) / (control cell OD-blank OD)) × 100
[0038] According to the above method, the cell adhesion rate of the prepared antibacterial wound dressing is 163%. It can be seen from the cell adhesion rate that the prepared antibacterial wound dressing has good cell adhesion and high cell affinity.
[0039] 3.3.4 Antibacterial performance testing
[0040] Antibacterial wound dressing and Staphylococcus aureus suspension (~10 5 The bacteria in the non-laser irradiation group were kept in the dark and incubated at 37°C, and then irradiated with a 600 nm laser (200 mW / cm 2 ) for 10 minutes. All solutions were spread on agarose plates and incubated at 37°C for 12 hours. Each experiment was performed in triplicate. The optical density (OD) of bacteria was read at 600 nm using a microplate reader.
[0041] Staphylococcus aureus suspension (~10 5 CFU / mL) and wound antibacterial dressings, and then irradiated with laser (600nm, 200mW / cm 2 , 10min). After every 2 hours of incubation, the wound antibacterial dressing was taken out and the absorbance of the solution at 600nm was recorded to calculate the bacterial growth curve.
[0042] The bacterial survival rate of wound antibacterial dressing treatment was 70.3%, which shows that wound antibacterial dressing has a certain antibacterial effect. However, the bacterial survival rate of wound antibacterial dressing and light treatment was 1.34%, indicating that wound antibacterial dressing after light showed good antibacterial effect. This is attributed to the production of ROS by wound antibacterial dressing under light, thereby inhibiting bacteria.
[0043] And under laser irradiation, the minimum inhibitory concentration (MIC) of the wound antibacterial dressing is 66.3μg / mL (manganese oxide doped phycocyanin concentration). The bacterial growth curve shows that the wound antibacterial dressing plus laser irradiation can inhibit bacterial growth. Therefore, from the above results, it can be concluded that the wound antibacterial dressing has good antibacterial properties.
[0044] 3.3.5 Drug resistance test
[0045] The wound antibacterial dressing was co-cultured with Staphylococcus aureus and then irradiated with laser (600nm, 200mW / cm 2 , 10min), and examine its minimum inhibitory concentration (MIC). Let Staphylococcus aureus grow for 5 generations continuously, and examine the change of its MIC. The results show that the MIC of the wound antibacterial dressing prepared in Example 1 has no obvious change, proving that the wound antibacterial dressing of the present invention will not cause Staphylococcus aureus to develop drug resistance under laser irradiation.
[0046] Example 2 (comparative experiment)
[0047] 1. Preparation of antibacterial wound dressing containing phycocyanin
[0048] Unmodified phycocyanin was dissolved in water to prepare an aqueous solution with a concentration of 1 mg / mL.
[0049] Weigh 100 mg of bacterial cellulose (purchased from Tianlu Nano Company, model NFC-31L1) and 15 mg of phycocyanin aqueous solution (1 mg / mL) and add them into water, stir to mix, slowly add sodium hydroxide aqueous solution (0.1 mol / L), adjust the pH to 11, pour into a mold to form, and freeze-dry to obtain an antibacterial wound dressing containing phycocyanin.
[0050] 2. Preparation of antibacterial wound dressing containing manganese oxide
[0051] Take manganese oxide nanoparticles and prepare an aqueous solution with a concentration of 1 mg / mL.
[0052] Weigh 100 mg of bacterial cellulose (purchased from Tianlu Nano Company, model NFC-31L1) and 15 mg of manganese oxide nanoparticle aqueous solution (1 mg / mL), add them into water, stir to mix, slowly add sodium hydroxide aqueous solution (0.1 mol / L), adjust the pH to 11, pour into a mold to form, and freeze-dry to obtain an antibacterial wound dressing containing manganese oxide.
[0053] 3. Preparation of bacterial nanofiber excipients
[0054] Weigh 100 mg of bacterial cellulose (purchased from Tianlu Nano Company, model NFC-31L1) and add it to water, stir to mix, slowly add sodium hydroxide aqueous solution (0.1 mol / L), adjust the pH to 11, pour it into a mold to form, and freeze-dry to obtain bacterial nanofiber auxiliary material.
[0055] 4. Comparison of antibacterial properties
[0056] The antibacterial properties of the phycocyanin-containing antibacterial wound dressing, the manganese oxide-containing antibacterial wound dressing and the bacterial nanofiber auxiliary material prepared by the comparative implementation were tested according to the method described in Example 1. The results are shown in Table 2.
[0057] Table 2 Antibacterial properties of different antibacterial wound dressings
[0058]
[0059] It can be seen from Table 2 that the antibacterial wound dressing prepared in Example 1 shows a more excellent antibacterial effect.
[0060] 4. Comparison of cell affinity properties of antimicrobial wound dressings
[0061] The cell affinity of the phycocyanin-containing antibacterial wound dressing, the manganese oxide-containing antibacterial wound dressing and the bacterial nanofiber auxiliary material prepared in Comparative Example 1 was tested according to the method described in Example 1. The results are shown in Table 3.
[0062] Table 3 Cell affinity properties of different antibacterial wound dressings
[0063]
[0064] It can be seen from Table 3 that the antibacterial wound dressing prepared in Example 1 shows more excellent cell affinity.
Claims
1. An antibacterial wound dressing, which is made of bacterial cellulose and 15% of the weight of bacterial cellulose manganese oxide doped with phycocyanin; wherein the manganese oxide doped with phycocyanin is made by the following method: Phycocyanin is added into pure water to prepare a phycocyanin aqueous solution; manganese dichloride in an amount 0.6 times the weight of the phycocyanin is added into pure water to prepare a manganese dichloride solution; the manganese dichloride solution and the phycocyanin aqueous solution are evenly mixed, sodium hydroxide aqueous solution is added dropwise, the pH value is adjusted to 9, the reaction is carried out at room temperature for 8 hours, and the manganese oxide-doped phycocyanin is obtained by dialyzing and freeze-drying.
2. An antibacterial wound dressing according to claim 1, It is characterized in that The antibacterial wound dressing is prepared by the following method: adding the bacterial cellulose and manganese oxide doped phycocyanin into water, dripping sodium hydroxide aqueous solution, adjusting the pH value to 11, pouring into a mold for forming, and freeze-drying to obtain the antibacterial wound dressing.
